GlaxoSmithKline Bets on Genetics Startup as Part of Research Overhaul

GlaxoSmithKline, under pressure to raise its game in research and development, said it would take a stake in a genetics startup and cut costs to spend more on developing new drugs.

from WSJ.com: US Business https://ift.tt/2OhTZgn
via IFTTT